NCI Drug Discovery and Development:
Accelerating the discovery and development of new anticancer agents
Download the CBC guide (pdf)
Sanford-Burnham's Conrad Prebys Center for Chemical Genomics is a proud member of NCI’s Drug Discovery and Development Program. The program is renowned for its success in taking late-stage preclinical drug candidates through the final steps of development to first-in-human studies. To advance the NCI’s mission of bringing novel therapies to patients, and to fully exploit NCI’s expertise in the later stage of preclinical development, the Institute is now focusing efforts and resources on drug candidate identification and optimization to enhance the entry of early-stage drug candidates into the NCI therapeutics pipeline.
We encourage all potential candidates to submit proposals to NCI-CBC.